Celldex Therapeutics
CLDX
CLDX
51 hedge funds and large institutions have $10.4M invested in Celldex Therapeutics in 2019 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
4% less funds holding
Funds holding: 53 → 51 (-2)
15% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 13
30% less capital invested
Capital invested by funds: $14.9M → $10.4M (-$4.47M)
Holders
51
Holding in Top 10
1
Calls
$201K
Puts
$141K
Top Buyers
| 1 | +$1.23M | |
| 2 | +$984K | |
| 3 | +$323K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$218K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$190K |
Top Sellers
| 1 | -$770K | |
| 2 | -$508K | |
| 3 | -$232K | |
| 4 |
VF
Virtu Financial
New York
|
-$127K |
| 5 |
Bank of New York Mellon
New York
|
-$126K |